168 related articles for article (PubMed ID: 10721817)
1. Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent.
Nilsson T; Lind H; Brunkvall J; Edvinsson L
Can J Physiol Pharmacol; 2000 Mar; 78(3):251-5. PubMed ID: 10721817
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
You J; Edvinsson L; Bryan RM
J Cereb Blood Flow Metab; 2001 Jan; 21(1):77-84. PubMed ID: 11149671
[TBL] [Abstract][Full Text] [Related]
3. Role of endothelium and nitric oxide in histamine-induced responses in human cranial arteries and detection of mRNA encoding H1- and H2-receptors by RT-PCR.
Jansen-Olesen I; Ottosson A; Cantera L; Strunk S; Lassen LH; Olesen J; Mortensen A; Engel U; Edvinsson L
Br J Pharmacol; 1997 May; 121(1):41-8. PubMed ID: 9146885
[TBL] [Abstract][Full Text] [Related]
4. Blunted pancreatic polypeptide-induced vasodilatation in mesenteric resistance vessels from spontaneously hypertensive rats.
Gradin KA; Li JY; Zhu H; Simonsen U
Eur J Pharmacol; 2008 Dec; 601(1-3):118-23. PubMed ID: 18851959
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y stimulates DNA synthesis in human vascular smooth muscle cells through neuropeptide Y Y1 receptors.
Nilsson T; Edvinsson L
Can J Physiol Pharmacol; 2000 Mar; 78(3):256-9. PubMed ID: 10721818
[TBL] [Abstract][Full Text] [Related]
6. Contractile effects of neuropeptide Y in human subcutaneous resistance arteries are mediated by Y1 receptors.
Nilsson T; Erlinge D; Cantera L; Edvinsson L
J Cardiovasc Pharmacol; 1996 Dec; 28(6):764-8. PubMed ID: 8961073
[TBL] [Abstract][Full Text] [Related]
7. In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.
Ekelund U; Erlinge D
Br J Pharmacol; 1997 Feb; 120(3):387-92. PubMed ID: 9031740
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of the neuropeptide Y (NPY) contractile and relaxing receptors in horse penile small arteries.
Prieto D; Arcos LR; Martínez P; Benedito S; García-Sacristán A; Hernández M
Br J Pharmacol; 2004 Dec; 143(8):976-86. PubMed ID: 15557288
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
Malmström RE
Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
[TBL] [Abstract][Full Text] [Related]
10. Evidence for Y1-receptor-mediated facilitatory, modulatory cotransmission by NPY in the rat anococcygeus muscle.
Hoyo Y; McGrath JC; Vila E
J Pharmacol Exp Ther; 2000 Jul; 294(1):38-44. PubMed ID: 10871293
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats.
Gradin KA; Buus CL; Li JY; Frøbert O; Simonsen U
Br J Pharmacol; 2006 Jul; 148(5):703-13. PubMed ID: 16715120
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide modulates neuropeptide Y regulation of ion transport in mouse ileum.
Rao RK; Lopez Y; Riviere PJ; Pascaud X; Junien JL; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):193-8. PubMed ID: 8764351
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y and its receptor analogs differentially modulate the immunoreactivity for neuronal or endothelial nitric oxide synthase in the rat brain following focal ischemia with reperfusion.
Chen SH; Cheung RT
J Biomed Sci; 2005; 12(2):267-78. PubMed ID: 15942706
[TBL] [Abstract][Full Text] [Related]
14. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
Malmström RE; Balmér KC; Lundberg JM
Br J Pharmacol; 1997 Jun; 121(3):595-603. PubMed ID: 9179405
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
[TBL] [Abstract][Full Text] [Related]
16. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.
Chu DQ; Cox HM; Costa SK; Herzog H; Brain SD
Br J Pharmacol; 2003 Sep; 140(2):422-30. PubMed ID: 12970079
[TBL] [Abstract][Full Text] [Related]
17. Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture.
Abounader R; Elhusseiny A; Cohen Z; Olivier A; Stanimirovic D; Quirion R; Hamel E
J Cereb Blood Flow Metab; 1999 Feb; 19(2):155-63. PubMed ID: 10027771
[TBL] [Abstract][Full Text] [Related]
18. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
Prieto D; Simonsen U; Nyborg NC
Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
[TBL] [Abstract][Full Text] [Related]
19. Renovascular effects of sympathetic cotransmitters ATP and NPY are age-dependent in spontaneously hypertensive rats.
Vonend O; Okonek A; Stegbauer J; Habbel S; Quack I; Rump LC
Cardiovasc Res; 2005 May; 66(2):345-52. PubMed ID: 15820203
[TBL] [Abstract][Full Text] [Related]
20. Functional effects of neuropeptide Y receptors on blood flow and nitric oxide levels in the human nose.
Cervin A; Onnerfält J; Edvinsson L; Grundemar L
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1724-8. PubMed ID: 10556147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
